DRUG-DRUG INTERACTION PROFILE OF TEZACAFTOR/ IVACAFTOR IN HEALTHY ADULT SUBJECTS

被引：0
|
作者：
Garg, V [1 ]
Shen, J. [1 ]
Li, C. [1 ]
Agarwal, S. [1 ]
Gebre, A. [1 ]
Parkinson, J. [1 ]
Robertson, S. [1 ]
Viswanathan, L. [1 ]
Huang, J. [1 ]
Han, L. [1 ]
Lekstrom-Himes, J. [1 ]
机构：
[1] Vertex Pharmaceut Inc, Boston, MA USA
来源：
PEDIATRIC PULMONOLOGY | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
254
引用
收藏
页码：S310 / S310
页数：1
相关论文
共 50 条
  • [31] Drug-drug interaction of ciprofol injectable emulsion with mefenamic acid capsules in healthy subjects
    Yang, Dandan
    Hu, Yin
    Ruan, Zourong
    Jiang, Bo
    Wang, Haiying
    Xu, Yichao
    Hu, Mengyue
    Yan, Min
    Lou, Honggang
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (10) : 3165 - 3174
  • [32] Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects
    Desai, Amit
    Yamazaki, Takao
    Dietz, Albert J.
    Kowalski, Donna
    Lademacher, Christopher
    Pearlman, Helene
    Akhtar, Shahzad
    Townsend, Robert
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (01): : 86 - 92
  • [33] Concomitant use of mirtazapine and cimetidine: a drug-drug interaction study in healthy male subjects
    Sitsen, JMA
    Maris, FA
    Timmer, CJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (05) : 389 - 394
  • [34] Evaluation of Drug-Drug Interaction Potential between Baloxavir Marboxil and Oseltamivir in Healthy Subjects
    Kawaguchi, Nao
    Koshimichi, Hiroki
    Ishibashi, Toru
    Wajima, Toshihiro
    CLINICAL DRUG INVESTIGATION, 2018, 38 (11) : 1053 - 1060
  • [35] Comparison of the Drug-Drug Interaction Potential of Daptomycin in Combination with Rifampin in Healthy Adult Volunteers
    Benefield, Russell J.
    Slechta, E. Susan
    Gast, Christopher M.
    Spivak, Emily S.
    Hanson, Kimberly E.
    Alexander, Donald P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (12)
  • [36] Safety, Pharmacokinetics, and Drug-Drug Interaction Potential of Intravenous Durlobactam, a β-Lactamase Inhibitor, in Healthy Subjects
    Lickliter, Jason D.
    Lawrence, Kenneth
    O'Donnell, John
    Isaacs, Robin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)
  • [37] An assessment of Drug-Drug interaction: the effect of desvenlafaxine succinate and Duloxetine on the pharmacokinetics of desipramine in healthy subjects
    Patroneva, A.
    Connolly, S.
    Fatato, P.
    Nichols, A.
    Paul, J.
    Guico-Pabia, C.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 334 - 335
  • [38] A DRUG-DRUG INTERACTION STUDY OF DS-1040 AND CLOPIDOGREL (CLO) IN HEALTHY SUBJECTS.
    Pizzagalli, F.
    Rambaran, C.
    Kobayashi, F.
    Pav, J.
    Warren, V.
    Vandell, A.
    Dishy, V.
    Zhou, J.
    Limsakun, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S73 - S73
  • [39] Drug-Drug Interaction of Letermovir and Atorvastatin in Healthy Participants
    McCrea, Jacqueline B.
    Menzel, Karsten
    Adedoyin, Adedayo
    Cho, Carolyn R.
    Fox-Bosetti, Sabrina
    Macha, Sreeraj
    Zhao, Tian
    Liu, Fang
    Panebianco, Deborah
    Stoch, S. Aubrey
    Iwamoto, Marian
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (04): : 420 - 428
  • [40] Drug-Drug Interaction and Biomarker Levels in Healthy Volunteers
    不详
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (01) : 19 - 19
12345